Found 75 matching trials
Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer
PHASE2Our study is aimed to evaluate the efficacy and safety of novel ADC named S...
Location
Fudan Cancer Hospital
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
PHASE2Research purposes: the research design in the late more than 2 lines TNBC p...
Location
Tianjin Cancer Hospital Airport Hospital
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
PHASE2This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Location
Banner MD Anderson Cancer Center
JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors
PHASE1This is a Phase I, open-label, multicenter, first-in-human study to evaluat...
Location
Scientia Clinical Research Ltd
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
PHASE3Researchers are looking for new ways to treat people with endometrial cance...
Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
N/AThe goal of this observational study is to evaluate and validate the expres...
Status
Active Not Recruiting
Location
Peking University First Hospital
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
PHASE2TROPION-DM/BrUOG-431 is a prospective, , phase 2 trial with two non-compara...
Location
Rhode Island and the Miriam Hospitals (Brown University Health)
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
PHASE2This study is a single-center, prospective, single-arm clinical trial, whic...
Location
Fudan University Shanghai Cancer center
Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
PHASE2This is an single-arm, multicenter phase II study to evaluate the safety an...
Location
West China Hospital of Sichuan University
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
PHASE2A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BN...